1. Home
  2. CNOBP vs CMMB Comparison

CNOBP vs CMMB Comparison

Compare CNOBP & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNOBP
  • CMMB
  • Stock Information
  • Founded
  • CNOBP N/A
  • CMMB 2004
  • Country
  • CNOBP United States
  • CMMB Israel
  • Employees
  • CNOBP 499
  • CMMB N/A
  • Industry
  • CNOBP Major Banks
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNOBP Finance
  • CMMB Health Care
  • Exchange
  • CNOBP Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • CNOBP N/A
  • CMMB 37.3M
  • IPO Year
  • CNOBP N/A
  • CMMB N/A
  • Fundamental
  • Price
  • CNOBP $23.22
  • CMMB $1.96
  • Analyst Decision
  • CNOBP
  • CMMB Strong Buy
  • Analyst Count
  • CNOBP 0
  • CMMB 2
  • Target Price
  • CNOBP N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • CNOBP N/A
  • CMMB 77.2K
  • Earning Date
  • CNOBP N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • CNOBP N/A
  • CMMB N/A
  • EPS Growth
  • CNOBP N/A
  • CMMB N/A
  • EPS
  • CNOBP N/A
  • CMMB N/A
  • Revenue
  • CNOBP N/A
  • CMMB N/A
  • Revenue This Year
  • CNOBP N/A
  • CMMB N/A
  • Revenue Next Year
  • CNOBP N/A
  • CMMB N/A
  • P/E Ratio
  • CNOBP N/A
  • CMMB N/A
  • Revenue Growth
  • CNOBP N/A
  • CMMB N/A
  • 52 Week Low
  • CNOBP N/A
  • CMMB $0.55
  • 52 Week High
  • CNOBP N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • CNOBP 57.14
  • CMMB 46.64
  • Support Level
  • CNOBP $23.10
  • CMMB $1.86
  • Resistance Level
  • CNOBP $23.28
  • CMMB $2.06
  • Average True Range (ATR)
  • CNOBP 0.18
  • CMMB 0.14
  • MACD
  • CNOBP -0.02
  • CMMB -0.02
  • Stochastic Oscillator
  • CNOBP 91.06
  • CMMB 30.30

About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: